Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
NIHR Bioresource Rare Diseases, |
RCV001027609 | SCV001190181 | pathogenic | Inherited Immunodeficiency Diseases | 2019-01-01 | criteria provided, single submitter | research | |
Labcorp Genetics |
RCV000015041 | SCV003442327 | uncertain significance | Ectodermal dysplasia and immunodeficiency 2 | 2022-09-23 | criteria provided, single submitter | clinical testing | Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on NFKBIA function (PMID: 17931563, 28629746). ClinVar contains an entry for this variant (Variation ID: 14004). This premature translational stop signal has been observed in individuals with clinical features of anhidrotic ectodermal dysplasia with T-cell immunodeficiency and/or primary immune deficiency (PMID: 17931563, 32581362; Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Trp11*) in the NFKBIA gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in NFKBIA cause disease. |
OMIM | RCV000015041 | SCV000035297 | pathogenic | Ectodermal dysplasia and immunodeficiency 2 | 2007-10-01 | no assertion criteria provided | literature only |